✦ LIBER ✦

Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers

✍ Scribed by Kazuya Kudoh; Masashi Takano; Hiroko Kouta; Ryoko Kikuchi; Tsunekazu Kita; Morikazu Miyamoto; Akio Watanabe; Masafumi Kato; Tomoko Goto; Yoshihiro Kikuchi

Book ID: 113963229
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 402 KB
Volume: 122
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.04.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin as a sin

Pegylated liposomal doxorubicin as a single agent or as combination therapy with carboplatin in patients with recurrent or refractory epithelial ovarian cancer

✍ Keng Shen; Beihua Kong; Yunong Gao; Lingying Wu; Ziting Li; Yile Chen; Mengda Li 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 360 KB

CA-125 response in patients with recurre

CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan

✍ Gabrielle Gossner; Robert L. Coleman; David G. Mutch; Neil S. Horowitz; Janet S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Pegylated liposomal doxorubicin with bev

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results

✍ S. Czok; A. Jewell; S. Shawki; L. Boyd; H. Smith; S. Blank; C. Muller; C. Versch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A phase II clinical trial of pegylated l

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Pegylated Liposomal Doxorubicin and Cycl

Pegylated Liposomal Doxorubicin and Cyclophosphamide as First-Line Therapy for Patients with Metastatic or Recurrent Breast Cancer

✍ Beth Overmoyer; Paula Silverman; Larry W. Holder; Debasish Tripathy; I. Craig He 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 493 KB

Meta-analysis of trials comparing gemcit

Meta-analysis of trials comparing gemcitabine and pegylated liposomal doxorubicin for treatment in women with progressive or recurrent ovarian cancer

✍ Xia Liu; Li Ma; Jinhui Tian; Kehu Yang 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 338 KB